The cost-effectiveness of pentavalent rotavirus vaccination in England and Wales.

Post navigation

← HPV vaccine introduction in Rwanda: Impacts on the broader health system

Determinants of childhood immunisation coverage in urban poor settlements of Delhi, India: a cross-sectional study →

VoICE is a project of the International Vaccine Access Center (IVAC) at the Johns Hopkins Bloomberg School of Public Health, and is made possible with support from the Bill & Melinda Gates Foundation. We thank the many partners who have contributed their time, energy and expertise to VoICE.

Learn More About IVAC
Contact Us

Translation Disclaimer